Creating a Sustainable Infrastructure for SARS-CoV-2 Testing (COVID-19) at Syringe Exchange Programs

NCT04852848 | Completed Results

• 2 other identifiers: 11162020.0133R01DA037628-05S1
• Study Type: interventional
• Target: 205
• Locations: 1 country
• Sites: 1

Brief Summary

PWIDs have been an underserved population in the context of the current pandemic; thus, little is known about the prevalence of COVID-19 and the acceptability and possible reach of testing for COVID-19 among PWIDs. To address this gap, this study leverages a current partnership with HIV Alliance (HIVA) in Oregon and our Community and Scientific Advisory Board to support implementation and sustainability of a COVID-19 testing program. Specifically, we will use community-based participatory approaches to develop, implement, and evaluate a COVID-19 testing program offered through HIVA's Syringe Services Programs (SSP), a natural point of care for PWIDs. The COVID-19 testing program will include procedures for sample collection, transmission of specimens to the University of Oregon CLIA-certified laboratory, and results reporting. Our clinical trial is a randomized control trial focused improving the uptake of testing through a motivational enhancement intervention: Connect2Test.

Conditions

Health Behavior

Outcome Measures

Primary Outcomes (1)

• Individual Participation in COVID-19 Testing

  Binary outcome, yes/no participated in COVID-19 tested, reported by CLIA laboratory

  Immediately post-intervention assessment of whether clients participated in COVID-19 testing following either the brief intervention or services as usual

Study Arms (2)

Connect2Test Intervention

EXPERIMENTAL

A brief MI intervention to motivate individuals to participate in COVID-19 testing after receiving syringe exchange services

Behavioral: Connect2Test Intervention

Control

NO INTERVENTION

Services as usual

Interventions

Connect2Test Intervention BEHAVIORAL

Brief assessment based feedback and motivational interviewing intervention

Connect2Test Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Aged 18 and over
• Attend Syringe Services Program
• English speaking

Sponsors & Collaborators

• University of Oregon: lead
• National Institute on Drug Abuse (NIDA): collaborator

Study Sites (1)

University of Oregon

Eugene, Oregon, 97403, United States

Location

Related Publications (1)

• Mauricio AM, Cioffi CC, Sanders AM, Kosty D, Fernandes L, Mueller MV, Stormshak EA. A mixed methods evaluation of a motivational enhancement intervention to increase SARS-CoV-2 testing among people experiencing houselessness and people who inject drugs. Psychol Serv. 2025 Nov;22(4):688-698. doi: 10.1037/ser0000939. Epub 2025 Mar 31.

  PMID: 40167545 DERIVED

MeSH Terms

Conditions

Health Behavior

Condition Hierarchy (Ancestors)

Behavior

Results Point of Contact

• Title: Anne Marie Mauricio, Research Associate Professor
• Organization: University of Oregon

amariem@uoregon.edu

602-920-7459

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 19, 2021
• First Posted: April 21, 2021
• Study Start: April 14, 2021
• Primary Completion: June 30, 2021
• Study Completion: June 30, 2021
• Last Updated: June 6, 2023
• Results First Posted: June 6, 2023

Record last verified: 2022-06

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF
• Time Frame: We will share IPD in the timeline put forth by the RADx-UP data coordinating center (CDCC)
• Access Criteria: We will share IPD in line with requirements and protocols put forth by the RADx-UP data coordinating center (CDCC)

Locations

US (1)